COTA, Inc. appointed Miruna Sasu, PhD as president and chief executive
officer.
AiCure has hired Andre Paredes, PhD, as Director of OpenDBM Community, Sarah Kark, PhD, as Senior Digital Neuroscientist, and Sondra Pepe, as VP of Product Operations.
CluePoints has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust as the new VP Business Operations.
Suvoda expanded its leadership team with the additions of Andrew McVeigh as Chief Architect and Steve DeSantisas Chief Financial Officer.
Qlucore appointed Erik Söderbäck as head of diagnostics sales.
BioIVT announced the appointment of Jennifer Murphy as Senior Vice President of Global Commercial Operations.
Daelight Solutions renewed its Preferred certification status for Implementation Support and Business Process/Strategy services for Veeva’s Vault eTMF.
ActiGraph joined the Decentralized Trials & Research Alliance.
Medidata announced Labcorp has selected their technology platform to extend their 14-year partnership.
AiCure opened its first international office in Nanjing, China.
Proxima Clinical Research was named to the Inc. Regionals 2022 Southwest list of the Fastest-Growing Private Companies; and was recognized by the Houston Business Journal as a company to watch, as noted in its inaugural Houston Inno Fire Awards.
Thermo Fisher Scientific won a 2021 TOPRA Award for Regulatory Excellence.
CluePoints won the Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.